Description
Description: Xeloda 500 mg Tablets are a potent chemotherapy medication manufactured by Roche Holding AG. Each tablet contains 500 milligrams (mg) of the active ingredient Capecitabine. This medication is an oral chemotherapy agent belonging to the class of fluoropyrimidine antimetabolites and is widely used in the treatment of various types of cancer.
Active Ingredient: The active ingredient in Xeloda is Capecitabine. Capecitabine is a prodrug that is converted into 5-fluorouracil (5-FU), a cytotoxic antimetabolite, in the body. 5-FU interferes with the synthesis of DNA and RNA in cancer cells, thereby inhibiting their growth and proliferation. It is effective against a wide range of cancers, including colorectal cancer, breast cancer, and gastric cancer.
Manufacturer: Xeloda 500 mg Tablets are manufactured by Roche Holding AG, a multinational healthcare company headquartered in Switzerland. Roche Holding AG is a leading player in the global pharmaceutical industry and is committed to developing innovative medications to improve patient outcomes.
Uses: Xeloda 500 mg Tablets are indicated for the treatment of several types of cancer, including:
- Colorectal cancer, either as first-line therapy or in combination with other chemotherapy drugs or radiation therapy.
- Metastatic breast cancer, either as monotherapy or in combination with other chemotherapy drugs.
- Gastric cancer or gastroesophageal junction (GEJ) cancer, either as first-line therapy or in combination with other chemotherapy drugs.
How to Use: Xeloda 500 mg Tablets should be taken orally with water, usually twice daily, within 30 minutes after a meal. The dosage and duration of treatment will vary depending on factors such as the type and stage of cancer being treated, as well as the patient’s overall health and response to therapy. It is essential to swallow the tablets whole and not to crush or chew them.
Storage Conditions: Xeloda 500 mg Tablets should be stored according to the manufacturer’s instructions, typically at room temperature away from heat, light, and moisture. The tablets should be kept in their original packaging and out of reach of children and pets.
Precautions:
- Xeloda 500 mg Tablets should be used with caution in patients with certain medical conditions, such as renal impairment, hepatic impairment, and dihydropyrimidine dehydrogenase (DPD) deficiency.
- Patients receiving Xeloda should undergo regular blood tests to monitor for potential side effects, such as bone marrow suppression and hand-foot syndrome.
- It is essential to inform the healthcare provider about any medications, supplements, or herbal products being taken before starting treatment with Xeloda.
Contraindications: Xeloda 500 mg Tablets are contraindicated in patients with a known hypersensitivity to Capecitabine or any of the components in the formulation. It should not be used in pregnant or breastfeeding women due to the potential risk of harm to the fetus or nursing infant.
Side Effects: Common side effects associated with Xeloda 500 mg Tablets may include nausea, vomiting, diarrhea, fatigue, hand-foot syndrome, and mucositis. More severe side effects, such as bone marrow suppression, cardiotoxicity, and hepatotoxicity, are possible but less common. Promptly report any unusual or severe symptoms to a healthcare provider.
Reviews
There are no reviews yet.